In an industry where a single clause can shift billions, Todd B. Richter operates with the calm of a surgeon. His toolkit was forged at the College of William and Mary (class of 1979) and sharpened at Indiana University’s Kelley School of Business (MBA 1981), where he learned to value intangibles like regulatory tailwinds alongside cash flows.
Eighteen years at Morgan Stanley saw Richter author the definitive reports on healthcare services. He flagged the rise of ambulatory surgery centers while others fixated on inpatient beds, earning 17 “All-American Analyst” nods and Wall Street Journal “All-Star” stripes. Investors leaned on his models during Clinton-era reforms and the dot-com bust.
Since 1999, Richter has run point at Bank of America’s Global Healthcare Investment Banking Group, closing marquee M&A and capital raises. Recent highlights include orchestrating a nine-figure merger of regional oncology networks and a PIPE for a CAR-T therapy innovator. Every term sheet reflects his dual mandate: maximize IRR while accelerating access to cutting-edge treatment.
Richter pays it forward through the $5 million Todd Richter Fund at Kelley, split evenly across graduate fellowships, securities analysis professorships, department resources, and Dean’s strategic purse. The structure guarantees that tomorrow’s deal-makers learn valuation the way he did—hands-on, data-drenched, and ethically grounded.
His softer side powers the Bideawee Todd B. Richter Foster Program, bankrolling vaccinations, microchips, and foster stipends to keep animals out of euthanasia queues. Alumni weekends at William and Mary and Indiana University often feature Richter recounting how a single fairness opinion saved a rural hospital—and a litter of puppies.
By fusing Wall Street precision with Main Street heart, Todd B. Richter redefines what a “successful” deal truly means.